Skip to main content
SpringerLink
Log in

Effect of Sirolimus in the Prevention of Adhesions Around Intraabdominal Prosthetic Graft

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Adhesions due to the reactions caused by the grafts used in primary vascular operations can lead to various problems when a secondary operation is necessary. These problems include bleeding, injuries to neighboring organs, and complications occurring due to a prolonged operation. We investigated the effects of sirolimus, which has antiproliferative features, on vascular adhesions.

Methods

The abdominal aorta of rats was explored and abrasions applied. Following the fixation of a polytetrafluoroethylene (PTFE) graft on the abdominal aorta, sirolimus (rapamycin) is applied (in powdered form) onto the grafts of the study group. Eight weeks later a laparotomy was repeated and any adhesions were evaluated.

Results

In the study group the adhesions were determined to be fewer in number and milder in severity. Severe cases of adhesion were determined in the control group.

Conclusions

Therefore, sirolimus applied around the prosthesis in vascular operations was determined to be effective at preventing possible adhesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1.
Figure 2.

Similar content being viewed by others

References

  1. Gutmann J, Penzias A, Diamond MP. Adhesions in reproductive surgery. In: Wallach E, Zacur HI, editors. Reproductive medicine and surgery. Missouri, Mosby 1995, pp 691–693

    Google Scholar 

  2. Whawell SA, Vipond MN, Scott-Coombes DM, et al. Plasminogen activator inhibitor-2 reduces peritoneal fibrinolytic activity in inflammation. Br J Surg 1993;80:107–109

    PubMed  CAS  Google Scholar 

  3. Sehgal SN, Baker H, Vezina C. Sirolimus (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation, and characterization. J Antibiot 1975;28:727–731

    PubMed  CAS  Google Scholar 

  4. Morris RE. Sirolimus: antifungal, antitumor, antiproliferative and immunosuppressive macrolides. Transplant Rev 1992;6:39–87

    Google Scholar 

  5. Roque M, Reis ED, Cordon-Cardo C, et al. Effect of p27 deficiency and sirolimus on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest 2001;81:895

    PubMed  CAS  Google Scholar 

  6. Marx SO, Marks AR. The development of sirolimus and its application to stent restenosis. Circulation 2001;104:852–855

    PubMed  CAS  Google Scholar 

  7. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001;103:192–195

    PubMed  CAS  Google Scholar 

  8. Sousa JE, Costa MA, Abizaid A, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents. One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007–2011

    PubMed  CAS  Google Scholar 

  9. Linsky CB, Diamond MP, Cunningham T, et al. Adhesion reduction in a rabbit uterine horn model using an absorbable barrier, TC-7. J Reprod Med 1987;32:17–20

    PubMed  CAS  Google Scholar 

  10. Naylor AR, Ah-See AK, Engeset J, et al. Graft occlusion following aortofemoral bypass for peripheral ischaemia. Br J Surg 1989;76(6):572–575

    PubMed  CAS  Google Scholar 

  11. Holmdahl L. Making and covering of surgical footprints. Lancet 1999;353(9163):1456–1457

    Article  PubMed  CAS  Google Scholar 

  12. Hendrikx M, Mees U, Hill AC, et al. Evaluation of a novel synthetic sealant for inhibition of cardiac adhesions and clinical experience in cardiac surgery procedures. Heart Surg Forum 2001;4(3):204–210

    Google Scholar 

  13. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg 1996;183:297–306

    PubMed  CAS  Google Scholar 

  14. Bakkum EA, Van Blitterswijk CA, Dalmeijer RAJ, et al. A semiquantitative rat model for intraperitoneal postoperative adhesion formation. Gynecol Obstet Invest 1994;37:99–105

    Article  PubMed  CAS  Google Scholar 

  15. Buckman RF, Woods M, Sargent L, et al. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976;20(1):1–5

    Article  PubMed  CAS  Google Scholar 

  16. Holmdahl L, Al-Jabreen M, Xia G, et al. The impact of starch powdered gloves on the formation of adhesions in rats. Eur J Surg 1994;160:257–261

    Google Scholar 

  17. Belluco C, Meggiolaro F, Pressato D. Prevention of postsurgical adhesions with an autocrosslinked hyaluronan derivative gel. J Surg Res 2001;100:217–221

    Article  PubMed  CAS  Google Scholar 

  18. Wiseman DM, Haung WJ, Johns DB, et al. Time-dependent effect of tolmetin sodium in rabbit uterine adhesion model. J Invest Surg 1994;7:527–532

    PubMed  CAS  Google Scholar 

  19. Kahan BD, Gibbons S, Tejpal N, et al. Synergistic interactions of cyclosporine and sirolimus to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 1991;51:232–239

    PubMed  CAS  Google Scholar 

  20. Tu Y, Stepkowski SM, Chou T-C, et al. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice. Transplantation 1995;59(2):177–183

    PubMed  CAS  Google Scholar 

  21. Knight R, Ferraresso M, Serino F, et al. Low-dose sirolimus potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model. Transplantation 1993;55(4):947–949

    Article  PubMed  CAS  Google Scholar 

  22. Ferraresso M, Tian L, Ghobrial R, et al. Sirolimus inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J Immunol 1994;153(7):3307–3318

    PubMed  CAS  Google Scholar 

  23. Segal SN, Camardo JS, Scarola JA, et al. Sirolimus (Sirolimus, rapamune). Curr Opin Nephrol Hypertens 1995;4:482–487

    Google Scholar 

  24. Molnar-Kimber KL, Rhoad A, Warner L, et al. Evidence that the anti-tumor and immunosuppressive effects of sirolimus are mediated via similar mechanisms. Cold Spring Harbor Meeting on Cell Cycle, 18–22 May 1994. New York, Cold Spring Harbor Laboratory, 1994, p 141

  25. Schachner T, Zou Y, Oberhuber A, et al. Local application of sirolimus inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 2004;77:1580–1585

    Article  PubMed  Google Scholar 

  26. Schatz RA, Penn IM, Baim DS. Stent restenosis study (STRESS): analysis of in-hospital results [abstract]. Circulation 1993;88[Suppl I]:1–594

    Google Scholar 

  27. Roque M, Cordon-Cardo C, Fuster V, et al. Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. Atherosclerosis 2000;153:315–322

    Article  PubMed  Google Scholar 

  28. Suzuki T, Kopia G, Hayashi S-I, et al. Stent based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188–1193

    PubMed  CAS  Google Scholar 

  29. Fukuda D, Sata M, Tanaka K, et al. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 2005;111:926–931

    Article  PubMed  CAS  Google Scholar 

  30. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 1998;98:82–89

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Cardiovascular Surgery, Kocaeli University School of Medicine, Kocaeli, Turkey

    Muhip Kanko MD, Ersan Ozbudak MD, Ali Ozerdem MD, Ahmet Aksoy MD, Metehan Kilic MD & K. Turan Berki MD

Authors
  1. Muhip Kanko MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ersan Ozbudak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali Ozerdem MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmet Aksoy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Metehan Kilic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Turan Berki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muhip Kanko MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanko, M., Ozbudak, E., Ozerdem, A. et al. Effect of Sirolimus in the Prevention of Adhesions Around Intraabdominal Prosthetic Graft. World J. Surg. 30, 1648–1652 (2006). https://doi.org/10.1007/s00268-005-0750-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-0750-1

Keywords

Search

Navigation